BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6493007)

  • 1. In vivo binding of spiroperidol and bromospiroperidol at low drug loadings.
    DeJesus OT; Revenaugh JR; Dinerstein RJ; Friedman AM
    Life Sci; 1984 Nov; 35(21):2165-8. PubMed ID: 6493007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous l-dopa alters spiroperidol binding, in vivo, in the mouse striatum.
    De Jesus OT; Van Moffaert GJ; Dinerstein RJ; Friedman AM
    Life Sci; 1986 Jul; 39(4):341-9. PubMed ID: 3736329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of [11C]spiroperidol in rat brain in vivo.
    Arnett CD; Fowler JS; Wolf AP; MacGregor RR
    J Neurochem; 1983 Feb; 40(2):455-9. PubMed ID: 6185638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR; Nahorski SR
    FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
    [No Abstract]   [Full Text] [Related]  

  • 5. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG; Friedhoff AJ; Bonnet KA
    Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H; Sudo K; Sano M
    Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
    Usdin TB; Creese I; Snyder SH
    J Neurochem; 1980 Mar; 34(3):669-76. PubMed ID: 6766497
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH; Wilcox RE; Vaughn DM; Smith RV
    Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Eur J Pharmacol; 1982 Aug; 82(3-4):243-4. PubMed ID: 7128691
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 11. 77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors.
    Owen F; Poulter M; Mashal RD; Crow TJ; Veall N; Zanelli GD
    Life Sci; 1983 Aug; 33(8):765-8. PubMed ID: 6888192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]spiroperidol: a radiopharmaceutical for the in vivo study of the dopamine receptor.
    Welch MJ; Raichle ME; Kilbourn MR; Mintun MA
    Ann Neurol; 1984; 15 Suppl():S77-8. PubMed ID: 6611130
    [No Abstract]   [Full Text] [Related]  

  • 13. Ex vivo 3H-spiroperidol binding to rat striatum and the inhibitory effects of neuroleptics.
    Nakajima T; Egawa E; Kuruma I
    Jpn J Pharmacol; 1981 Apr; 31(2):159-64. PubMed ID: 6118446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors.
    Mazière B; Loc'h C; Hantraye P; Guillon R; Duquesnoy N; Soussaline F; Naquet R; Comar D; Mazière M
    Life Sci; 1984 Sep; 35(13):1349-56. PubMed ID: 6332966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.
    Le Fur G; Phan T; Uzan A
    Life Sci; 1980 Apr; 26(14):1139-48. PubMed ID: 7392792
    [No Abstract]   [Full Text] [Related]  

  • 17. Solubilisation of high-affinity dopamine receptors.
    Gorissen H; Laduron P
    Nature; 1979 May; 279(5708):72-4. PubMed ID: 450076
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats.
    Bhargava HN
    Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
    Howlett DR; Nahorski SR
    Life Sci; 1980 Feb; 26(7):511-7. PubMed ID: 7366332
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.